<SEC-DOCUMENT>0001477932-25-001343.txt : 20250228
<SEC-HEADER>0001477932-25-001343.hdr.sgml : 20250228
<ACCEPTANCE-DATETIME>20250228090015
ACCESSION NUMBER:		0001477932-25-001343
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250228
DATE AS OF CHANGE:		20250228

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Health Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86294
		FILM NUMBER:		25683038

	BUSINESS ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cosmos Holdings Inc.
		DATE OF NAME CHANGE:	20140106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Siokas Grigorios
		CENTRAL INDEX KEY:			0001660125
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		5 AG. GEORGIOU STR., PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			TK57001
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:ns0="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001660125</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>4</amendmentNo>
<securitiesClassTitle>Common Stock, Par Value $0.001 per share</securitiesClassTitle>
<dateOfEvent>02/24/2025</dateOfEvent>
<previouslyFiledFlag>true</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001474167</issuerCIK>
<issuerCUSIP>221413206</issuerCUSIP>
<issuerName>Cosmos Health Inc.</issuerName>
<address>
<ns0:street1>5 AG. GEORGIOU STR., PILEA</ns0:street1>
<ns0:city>THESSALONIKI</ns0:city>
<ns0:stateOrCountry>J3</ns0:stateOrCountry>
<ns0:zipCode>TK57001</ns0:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Elliot H. Lutzker</personName>
<personPhoneNum>646-428-3210</personPhoneNum>
<personAddress>
<ns0:street1>605 Third Avenue</ns0:street1>
<ns0:city>New York</ns0:city>
<ns0:stateOrCountry>NY</ns0:stateOrCountry>
<ns0:zipCode>10158</ns0:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001660125</reportingPersonCIK>
<reportingPersonName>Grigorios Siokas</reportingPersonName>
<fundType>PF</fundType>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>J3</citizenshipOrOrganization>
<soleVotingPower>4609399</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>4609399</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>4609399</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>16.6</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>N/A</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Common Stock, Par Value $0.001 per share</securityTitle>
<issuerName>Cosmos Health Inc.</issuerName>
<issuerPrincipalAddress>
<ns0:street1>5 AG. GEORGIOU STR., PILEA</ns0:street1>
<ns0:city>THESSALONIKI</ns0:city>
<ns0:stateOrCountry>J3</ns0:stateOrCountry>
<ns0:zipCode>TK57001</ns0:zipCode>
</issuerPrincipalAddress>
</item1>
<item2>
<filingPersonName>Grigorios Siokas</filingPersonName>
<principalBusinessAddress>5AG Georgiou Str., Pilea, Thessaloniki J3TK 57001</principalBusinessAddress>
<principalJob>CEO, Cosmos Health, Inc., 5 Agiou Georgiou Str., Pilea, Thessaloniki, Greece J3TK 57001</principalJob>
<hasBeenConvicted>No civil proceedings to be disclosed</hasBeenConvicted>
<convictionDescription>No criminal proceedings to be disclosed</convictionDescription>
<citizenship>Greece</citizenship>
</item2>
<item3>
<fundsSource>Personal funds, none of which have been borrowed.</fundsSource>
</item3>
<item4>
<transactionPurpose>There are no plans or proposals which the reporting person has which may result in any of the matters listed.</transactionPurpose>
</item4>
<item5>
<percentageOfClassSecurities>4,609,399 (16.6%) shares based on 26,979,875 shares issued and outstanding on February 26, 2025.</percentageOfClassSecurities>
<numberOfShares>Sole voting power and disposition power - 4,609,399 shares; includes 3,897,016 issued shares; 212,383 shares issuable upon exercise of Exchange Warrants issued on October 20, 2022, pursuant to a Warrant Exchange Agreement dated as of October 3, 2022; and 500,000 shares issuable upon exercise of Series B Common Warrants exercisable at $3.00 per share sold pursuant to Registration Statement No. 333-267917.</numberOfShares>
<transactionDesc>On January 30, 2024, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 51,414 shares of common stock at an Exchange Rate of $0.6613 per share, or an aggregate of approximately $34,000, the fair market value of the Common Shares, in exchange for $34,000 the Company owed Mr. Siokas. &#13; On February 11, 2024, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 108,510 shares of common stock at an Exchange Rate of $0.6451 per share, or an aggregate of approximately $70,000, the fair market value of the Common Shares, in exchange for $70,000 the Company owed Mr. Siokas. On February 13, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 70,313 shares of common stock at an Exchange Rate of $0.64 per share, or an aggregate of approximately $45,000, the fair market value of the Common Shares, in exchange for $45,000 the Company owed Mr. Siokas.&#13; On February 24, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 354,296 shares of common stock at an Exchange Rate of $0.5645 per share, or an aggregate of approximately $200,000, the fair market value of the Common Shares, in exchange for $200,000 the Company owed Mr. Siokas.</transactionDesc>
<listOfShareholders>No person has the right to receive, or the power to direct the receipt of dividends from, or proceeds from, the sale of such securities.</listOfShareholders>
<date5PercentOwnership>Not applicable.</date5PercentOwnership>
</item5>
<item6>
<contractDescription>None</contractDescription>
</item6>
<item7>
<filedExhibits>None</filedExhibits>
</item7>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Grigorios Siokas</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Grigorios Siokas</signature>
<title>Chief Executive Officer</title>
<date>02/27/2025</date>
</signatureDetails>
</signaturePerson>
<commentText>The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.&#13; &#13; Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).</commentText>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
